Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring is a peer-reviewed, open access journal published by Wiley on behalf of the Alzheimer's Association. As a premier title in the field, it holds a Q1 ranking in the Journal Citation Reports, reflecting its high impact and rigorous scientific standards. The journal is exclusively dedicated to advancing the understanding and clinical management of Alzheimer's disease and other dementias, with a specific focus on the critical areas of diagnosis, assessment, and disease monitoring. Its scope encompasses a wide range of topics, including biomarker discovery and validation (from CSF and plasma to neuroimaging), novel diagnostic criteria, neuropsychological assessment, cognitive and functional outcome measures, digital health technologies for monitoring disease progression, and the development of surrogate endpoints for clinical trials. The journal publishes original research articles, brief reports, and review articles, alongside special features such as commentaries and methodological papers. Its target audience is multidisciplinary, including neurologists, geriatricians, psychiatrists, neuropsychologists, clinical researchers, epidemiologists, and pharmaceutical scientists involved in dementia research and care. Notably, as an open access publication, all articles are freely available to a global readership, ensuring rapid dissemination of critical findings. By concentrating on the translational pipeline from diagnostic innovation to practical monitoring tools, this journal serves as an essential resource for researchers and clinicians seeking to improve early detection, track disease trajectories, and evaluate therapeutic efficacy in the fight against dementia.